Predictive modeling of glioblastoma recurrence for therapeutic target identification
Patient-derived xenograft (PDX) models are an essential resource in cancer research, enabling the discovery of novel molecular mechanisms and therapeutic targets, while providing a preclinical platform for the evaluation of experimental treatments. For glioblastoma (GB), the most malignant primary b...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2025-04-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.1038/s44321-025-00236-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|